These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24840267)

  • 1. Impact of diet and exercise on lipid management in the modern era.
    Franklin BA; Durstine JL; Roberts CK; Barnard RJ
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):405-21. PubMed ID: 24840267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL and lifestyle interventions.
    Escolà-Gil JC; Julve J; Griffin BA; Freeman D; Blanco-Vaca F
    Handb Exp Pharmacol; 2015; 224():569-92. PubMed ID: 25523002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and management of the dyslipidemia of the metabolic syndrome.
    Raal FJ
    Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waging war on modern chronic diseases: primary prevention through exercise biology.
    Booth FW; Gordon SE; Carlson CJ; Hamilton MT
    J Appl Physiol (1985); 2000 Feb; 88(2):774-87. PubMed ID: 10658050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation.
    Khattab AA; Knecht M; Meier B; Windecker S; Schmid JP; Wilhelm M; Saner H
    Eur J Prev Cardiol; 2013 Oct; 20(5):743-9. PubMed ID: 22547410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyslipidemia: management using optimal lipid-lowering therapy.
    Ito MK
    Ann Pharmacother; 2012 Oct; 46(10):1368-81. PubMed ID: 23032652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
    Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
    Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular physical activity as a basic component of lifestyle modification reduces major cardiovascular risk factors among male armored force personnel of Shabestar army installation in Iran.
    Naghii MR; Almadadi M; Zarchi AA
    Work; 2011; 40(2):217-27. PubMed ID: 21876276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise and diet, independent of weight loss, improve cardiometabolic risk profile in overweight and obese individuals.
    Gaesser GA; Angadi SS; Sawyer BJ
    Phys Sportsmed; 2011 May; 39(2):87-97. PubMed ID: 21673488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthy lifestyles and cardiovascular risk profiles in young Australian adults: the Childhood Determinants of Adult Health Study.
    Gall SL; Jamrozik K; Blizzard L; Dwyer T; Venn A
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):684-9. PubMed ID: 19734791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low HDL-cholesterol--an important risk factor for cardiovascular diseases].
    Reiner Z; Muacević-Katanec D; Katanec D; Tedeschi-Reiner E
    Lijec Vjesn; 2011; 133(3-4):111-6. PubMed ID: 21612108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lifestyle modification - is it worth it?].
    Gohlke H
    Herz; 2004 Feb; 29(1):139-44. PubMed ID: 14968351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Rehabilitation: Underrecognized/Underutilized.
    Franklin BA; Brinks J
    Curr Treat Options Cardiovasc Med; 2015 Dec; 17(12):62. PubMed ID: 26526338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing the lipid profile of coronary heart disease patients.
    Drakopoulou M; Toutouzas K; Stathogiannis K; Synetos A; Trantalis G; Tousoulis D
    Expert Rev Cardiovasc Ther; 2016 Nov; 14(11):1263-1271. PubMed ID: 27552726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European and American recommendations for coronary heart disease prevention.
    Wood D
    Eur Heart J; 1998 Feb; 19 Suppl A():A12-9. PubMed ID: 9519337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lifestyle intervention for the prevention of cardiovascular disease].
    Fokkema MR; Muskiet FA; van Doormaal JJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(47):2607-12. PubMed ID: 16355572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for treating lipids for prevention: risk stratification models with and without imaging.
    Okwuosa TM; Mallikethi-Reddy S; Jones DM
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):295-307. PubMed ID: 24840260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.